Irene Toledo-Garcia
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pharmacological modulation with the LXR agonist T0901317 attenuates motor pathology in the SOD1G93A mouse model of ALS.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: May 28, 2026
RNA-binding protein IMP1/ZBP1 directs local translation in microglial processes to regulate motility and phagocytosis during inflammation.
Journal: PLoS biology
Published: June 11, 2025
TDP-43 dysregulation impairs cholesterol metabolism linked with myelination defects.
Journal: Acta neuropathologica
Published: March 18, 2025
Corrigendum to "TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43" [Neurobiology of disease Volume 193, April 2024, 106437].
Journal: Neurobiology of disease
Published: October 27, 2024
In vivo diagnosis of TDP-43 proteinopathies: in search of biomarkers of clinical use.
Journal: Translational neurodegeneration
Published: January 16, 2024
TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43.
Journal: Neurobiology of disease
Published: December 15, 2023
Leptin haploinsufficiency exerts sex-dependent partial protection in SOD1G93A mice by reducing inflammatory pathways in the adipose tissue.
Journal: Scientific reports
Published: November 07, 2023
Mutation in the FUS nuclear localisation signal domain causes neurodevelopmental and systemic metabolic alterations.
Journal: Disease models & mechanisms
Published: March 21, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026